Inmode Ltd
NASDAQ:INMD

Watchlist Manager
Inmode Ltd Logo
Inmode Ltd
NASDAQ:INMD
Watchlist
Price: 15.705 USD -1.97% Market Closed
Market Cap: $992.7m

Net Margin

41.1%
Current
Improving
by 1.7%
vs 3-y average of 39.4%

Net Margin shows how much profit a company keeps from each dollar of sales after all expenses, including taxes and interest. It reflects the company`s overall profitability.

Net Margin
41.1%
=
Net Income
$149.8m
/
Revenue
$364.5m

Net Margin shows how much profit a company keeps from each dollar of sales after all expenses, including taxes and interest. It reflects the company`s overall profitability.

Net Margin
41.1%
=
Net Income
$149.8m
/
Revenue
$364.5m

Peer Comparison

Country Company Market Cap Net
Margin
IL
Inmode Ltd
NASDAQ:INMD
993m USD
Loading...
US
Abbott Laboratories
NYSE:ABT
190.1B USD
Loading...
US
Intuitive Surgical Inc
NASDAQ:ISRG
181.4B USD
Loading...
US
Stryker Corp
NYSE:SYK
140.5B USD
Loading...
US
Boston Scientific Corp
NYSE:BSX
139.4B USD
Loading...
IE
Medtronic PLC
NYSE:MDT
131.6B USD
Loading...
US
Becton Dickinson and Co
NYSE:BDX
58.1B USD
Loading...
DE
Siemens Healthineers AG
XETRA:SHL
47.2B EUR
Loading...
US
IDEXX Laboratories Inc
NASDAQ:IDXX
54.1B USD
Loading...
US
Edwards Lifesciences Corp
NYSE:EW
47.4B USD
Loading...
US
Resmed Inc
NYSE:RMD
37.1B USD
Loading...

Market Distribution

Higher than 91% of companies in Israel
Percentile
91th
Based on 749 companies
91th percentile
41.1%
Low
-85 210% — -8.6%
Typical Range
-8.6% — 7.2%
High
7.2% — 23 652.1%
Distribution Statistics
Israel
Min -85 210%
30th Percentile -8.6%
Median 1.8%
70th Percentile 7.2%
Max 23 652.1%

Inmode Ltd
Glance View

InMode Ltd., founded in 2008, has emerged as a dynamic player in the field of minimally invasive aesthetic medical treatments. Born during a period where the health and beauty sectors were experiencing rapid technological innovation, the company quickly carved a niche for itself by addressing a clear market need: the rising demand for non-surgical procedures. At its heart, InMode merges the precision of medical technology with the principles of aesthetic enhancement. Its primary offerings revolve around radio-frequency-based devices that healthcare providers use to achieve results that traditionally required more invasive techniques. This includes skin tightening, fat reduction, and body contouring solutions, all tailored to meet the growing consumer appetite for treatments that carry less downtime and risk compared to conventional surgery. The company monetizes its expertise by manufacturing and selling these state-of-the-art devices to a diverse group of users, ranging from dermatologists and plastic surgeons to aesthetic practices. InMode's revenue streams are bolstered by not only the direct sale of these devices but also by ongoing client relationships through service agreements and consumable products that are essential for their machine operation. It is a model that ensures continuous engagement with their clients, providing both stability and growth in revenue. By focusing on innovation and efficacy, InMode has successfully captured a significant share of the aesthetic medical market, embodying a business strategy that combines cutting-edge technology with practical solutions to consumer needs.

INMD Intrinsic Value
HIDDEN
Show
What is Net Margin?
Net Margin shows how much profit a company keeps from each dollar of sales after all expenses, including taxes and interest. It reflects the company`s overall profitability.
How is Net Margin calculated?

Net Margin is calculated by dividing the Net Income by the Revenue.

Net Margin
41.1%
=
Net Income
$149.8m
/
Revenue
$364.5m
What is Inmode Ltd's current Net Margin?

The current Net Margin for Inmode Ltd is 41.1%, which is above its 3-year median of 39.4%.

How has Net Margin changed over time?

Over the last 3 years, Inmode Ltd’s Net Margin has increased from 40.9% to 41.1%. During this period, it reached a low of 35.5% on Dec 31, 2022 and a high of 45.9% on Dec 31, 2024.

Back to Top